Sofinnova Investments’s Syndax Pharmaceuticals SNDX Stock Holding History

Sofinnova Investments’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,524,440	Closed	-$14.3M	–	73
2025 Q2	$14.3M	Sell	1,524,440 -750,783	-33%	-$8.26M	0.87%	33
2025 Q1	$28M	Buy	2,275,223 +1,616,596	+245%	+$22.8M	1.83%	16
2024 Q4	$8.71M	Sell	658,627 -128,372	-16%	-$2.2M	0.63%	35
2024 Q3	$15.1M	Sell	786,999 -1,366,670	-63%	-$28.2M	1.2%	21
2024 Q2	$44.2M	Buy	2,153,669 +545,129	+34%	+$11.4M	2.3%	13
2024 Q1	$38.3M	Buy	1,608,540 +532,754	+50%	+$11.9M	2.13%	16
2023 Q4	$23.2M	Buy	1,075,786 +133,969	+14%	+$2.06M	1.3%	21
2023 Q3	$13.7M	Sell	941,817 -640,474	-40%	-$12.1M	0.86%	32
2023 Q2	$33.1M	Buy	1,582,291 +506,867	+47%	+$10.6M	2.17%	14
2023 Q1	$22.7M	Buy	1,075,424 +372,350	+53%	+$9.26M	1.45%	20
2022 Q4	$17.9M	Buy	703,074 +178,072	+34%	+$4.15M	1.06%	23
2022 Q3	$12.6M	Buy	525,002 +111,574	+27%	+$2.5M	0.73%	28
2022 Q2	$7.95M	Sell	413,428 -303,636	-42%	-$5.06M	0.66%	31
2022 Q1	$12.5M	Sell	717,064 -234,162	-25%	-$3.94M	0.95%	27
2021 Q4	$20.8M	Buy	951,226 +537,385	+130%	+$9.93M	1.22%	24
2021 Q3	$7.91M	Buy	+413,841	New	+$6.9M	0.47%	45
2021 Q2	–	Sell	-298,644	Closed	-$6.68M	–	75
2021 Q1	$6.68M	Sell	298,644 -74,265	-20%	-$1.68M	0.4%	44
2020 Q4	$8.29M	Buy	+372,909	New	+$7.73M	0.49%	40
2020 Q3	–	Sell	-91,964	Closed	-$1.36M	–	86
2020 Q2	$1.36M	Buy	+91,964	New	+$1.4M	0.09%	67
2019 Q4	–	Sell	-243,150	Closed	-$1.82M	–	69
2019 Q3	$1.82M	Buy	243,150 +421	+0.2%	+$3.83K	0.16%	60
2019 Q2	$2.26M	Buy	242,729 +29,370	+14%	+$214K	0.21%	53
2019 Q1	$1.12M	Sell	213,359 -136,751	-39%	-$780K	0.11%	60
2018 Q4	$1.56M	Buy	350,110 +176,998	+102%	+$970K	0.19%	55
2018 Q3	$1.4M	Buy	173,112 +74,499	+76%	+$531K	0.12%	55
2018 Q2	$693K	Buy	98,613 +86,489	+713%	+$849K	0.08%	55
2018 Q1	$173K	Buy	+12,124	New	+$129K	0.03%	50